YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Yubo International Biotech Ltd
Financials through Q2 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $886.19K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0084 (−61.76%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Yubo International Biotech Ltd reported revenue of $12.35K for the twelve months to Jun 30, 2026.
Revenue
$12.35K
TTM Q2 2027
Operating income
-$1.12M
TTM Q2 2027
EPS, diluted
$0.00
TTM Q2 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $886.19K
- P/E ratio
- –
- Price to sales
- 71.74
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $12.35K
- Net income
- -$1.01M
- EPS, diluted
- $0.00
- Book value per share
- -$0.02
- Diluted shares
- 170M
Fifteen years at a glance
Fiscal years 2011 to 2026 and trailing twelve months, USD
Revenue
$12.35K
Gross profit
$8.17K
Operating income
-$1.12M
Net income
-$1.01M
EPS, diluted
$0.00
Free cash flow
–
Reported periodTrailing twelve months